A programmable encapsulation system improves delivery of therapeutic bacteria in mice
2022 · Nature Biotechnology · 223 citations
https://doi.org/10.1038/s41587-022-01244-y
F
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
103
Papers
865
Citations
9
h-index
9
i10-index
Fangda Li is an academic researcher from Chinese Academy of Medical Sciences & Peking Union Medical College. The author has contributed to research in topics: Circular RNAs in diseases & MicroRNA in disease regulation & Cancer Research and Treatments. The author has an h-index of 9, co-authored 88 publications.
ORCID: 0000-0002-4697-3989Papers by this author
worksProbiotic-guided CAR-T cells for solid tumor targeting
2023 · Science · 217 citations
https://doi.org/10.1126/science.add7034
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
2024 · Nature · 119 citations
https://doi.org/10.1038/s41586-024-08033-4
Supplementary Figure 1 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
2024 · 0 citations
https://doi.org/10.1158/2159-8290.25191599.v1
Supplementary Tables 1 - 4 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
2024 · 0 citations
https://doi.org/10.1158/2159-8290.25191554.v1
Supplementary Figure 6 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
2024 · 0 citations
https://doi.org/10.1158/2159-8290.25191581
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat